Veracyte Completes Acquisition of Decipher Biosciences

Veracyte to Acquire Decipher Biosciences

Decipher Test Clinically Validated as a Predictor of Overall Survival in Men with Prostate Cancer

eviCore Clinical Guidelines Incorporate Decipher Prostate into New Medical Necessity Criteria for Prostate Cancer Patients

Decipher Biosciences Achieves Major Medicare Milestone with Expansion in Coverage for Decipher Prostate Genomic Testing

Decipher Identifies a Molecular Subtype Most Likely to Benefit from Neoadjuvant KEYTRUDA Immunotherapy in Bladder Cancer Patients

NCCN Guidelines Designate Decipher Prostate as “Recommended” for Men with Adverse Pathology after Radical Prostatectomy

Decipher Prostate RP Identifies Patients Likely to Benefit from Hormonal Therapy in Men with Recurrent Prostate Cancer